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and easy to complete. The measure will be further tested in additional 
qualitative and quantitative studies to evaluate its measurement properties.  
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OBJECTIVES: There has been a growing interest in developing country-specific 
scoring algorithms for the EQ-5D around the world. This study systematically 
reviews all existing EQ-5D valuation studies to highlight their strengths and 
limitations, explores heterogeneity in observed utilities using meta-regression, 
and proposes a methodological checklist, the Checklist for Valuation Studies of 
the EQ-5D (CREATE) for reporting EQ-5D valuation studies. METHODS: We 
searched Medline, EMBASE, the National Health Service Economic Evaluation 
Database (NHS EED) via Wiley’s Cochrane Library, and Wiley’s Health Economic 
Evaluation Database from inception through November 2012, as well as 
bibliographies of key papers and the EuroQol Plenary Meeting Proceedings from 
1991 to 2012 for English-language reports of EQ-5D valuation studies. Two 
reviewers independently screened the titles and abstracts for relevance. Three 
reviewers performed data extraction and compared the characteristics and 
scoring algorithms developed in the included valuation studies. RESULTS: Of the 
31 studies included in the review, 19 used the time trade-off (TTO) technique, 10 
used the visual analogue scale (VAS) technique, and 2 used both TTO and VAS. 
Most studies used respondents from the general population selected by random 
or quota sampling, and face-to-face interviews or postal surveys. Studies valued 
between 7 and 198 total states, with 1 to 23 states valued per respondent. 
Different model specifications have been proposed for scoring. Some sample or 
demographic factors, including gender, education, per cent urban population, 
and national health care expenditure were associated with differences in 
observed utilities for moderate or severe health states. CONCLUSIONS: EQ-5D 
valuation studies conducted to date have varied widely in their design and in the 
resulting scoring algorithms. Therefore, we propose the CREATE for those 
conducting valuation studies.  
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OBJECTIVES: Consistency between translated clinical outcome assessments and 
corresponding rater training documentation is critical for global clinical trials. If 
the translation of rater training materials is completed independently or without 
reference to the linguistically validated clinical outcomes assessments, 
inconsistencies between the scale and the rater training materials are created. 
Steps must be taken to ensure consistency between rater training materials and 
their corresponding scales. METHODS: A review of prior projects involving rater 
training materials and corresponding scales, as well as discussion with Sponsors 
who have conducted translations with other organizations was conducted to 
provide insight into key areas where reference between the translation of the 
clinical outcomes assessment and the rater training material proved critical. 
RESULTS: Reviews of prior projects revealed that early reference to previously 
translated scales yielded improved linguistic consistencies between overlapping 
text found in rater training documentation, as well as yielding time efficiencies. 
If the rater training documentation was translated independently of the scale, 
inconsistencies existed between the scale and the rater training materials. This 
required additional reconciliation efforts, adding both timeline and cost to the 
project scope to rectify the inconsistencies. By centralizing the translation 
process for these documents, the inconsistencies were eliminated, and the 
additional cost and timeline for a secondary reconciliation process was avoided. 
CONCLUSIONS: It is important that the content used to train raters is consistent 
with the actual scale they will be using. If the translations are completed without 
reference to the scale, there will be inconsistent text that could ultimately 
confuse the rater and generate inaccurate results. Centralization of the rater 
training material translations and scale translations, or providing the translation 
provider completing the rater training documentation with the relevant scale 
translations for reference before project initiation, maximizes consistency 
between clinical outcome assessment translations and their corresponding rater 
training documentation.  
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OBJECTIVES: Researchers at Oxford are developing a new self-reported assessment 
tool called the e-Health Impact Questionnaire (e-HIQ), which will be used to assess 
the impact of using health-related websites. A translatability assessment was 
performed on the draft items to establish whether they will be cross-culturally and 
linguistically valid should the questionnaire be translated in the future. METHODS: 
A concept elaboration document was produced in order to expand on the items 
within the e-HIQ; this was sent to medical translators in six countries who provided 
feedback on the translatability of the text from linguistic and cultural perspectives. 
The project manager reviewed the recommendations from each translator and 
suggested changes to the e-HIQ developer. This was followed by a teleconference 
between the developer and the project manager, during which the suggested 
changes were discussed and implemented to ensure the e-HIQ will be more easily 
translated in the future. Finally, a report detailing the whole process was created 
and submitted to the developer. RESULTS: Several changes were deemed necessary 
as a result of the translatability assessment. These changes included clarifying the 
intended tense of ‘I may face’ in order to avoid mistranslation, and changing the 
phrase ‘taking steps’ to ‘taking actions’, retaining the positive tone yet avoiding a 
literal translation. There were also three questions that, although distinct in 
English, have overlapping meanings when translated. The questions included the 
terms ‘solidarity’, ‘have a lot in common’ and ‘identify with people’. Although clear 
terms in English, many languages only have one way of saying all three terms and 
therefore a change was advised. CONCLUSIONS: This study highlights the 
importance of including a translatability assessment during the development of a 
measure as it enables developers to incorporate an international element into its 
development. In turn, this will enable an easier transition into various translations.  
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OBJECTIVES: While requirements for identifying cognitive interviewing 
respondents are not specifically outlined in the FDA Guidance for Industry 
Patient-Reported Outcome Measures, best practices dictate that respondents 
should be as closely representative of the study patient population as possible. 
For a questionnaire intended for a single patient population or a study with a 
single patient population, this concept is sufficient for determining criteria. On 
the other hand, some cases lend themselves to the use of multiple patient 
populations and more varied respondent criteria. METHODS: Past translation 
and linguistic validation projects that included cognitive interviewing of multiple 
patient populations were reviewed along with the process for determining their 
respective respondent criteria. RESULTS: For each project, the goal of cognitive 
interviewing was to determine patient understanding of concepts in the 
intended study population. As such, respondent inclusion criteria were 
developed to represent the intended study population as closely as possible. 
Criteria ranged from multiple cancer types, to multiple age groups, as well as 
caregiver and patient mixtures. In each case, more than one respondent of each 
sub-category was required in order to ensure sufficient feedback. CONCLUSIONS: 
Cognitive interviewing of a single patient population typically includes around 5 
respondents. With multiple populations, an increased total number of 
respondents are recommended. Balancing this with study budget and timeline 
restrictions presents a challenge. While exact representation of multiple patient 
populations may not be possible, development of a more broadly representative 
criteria that still includes multiple populations proves beneficial in ensuring that 
a questionnaire is fit for purpose.  
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OBJECTIVES: The SF-36 and SF-12 are generic health-related quality of life 
(HRQoL) instruments used in many areas of research, including spinal cord 
injury (SCI). Repeated concerns have been raised within the broader disability 
literature about the appropriateness of such measures for subjects with 
significant physical impairment, yet continued use is widespread. This 
systematic review provides a comprehensive descriptive overview of how the SCI 
research community has adopted variants of the ‘short form’ HRQoL 
instruments. METHODS: A systematic database and bibliographic search was 
conducted to identify SCI-related publications reporting outcome data using a 
HRQoL instrument related to the 36-item and 12-item short form measures (e.g. 
SF-36, SF-12, RAND-36, RAND-12, SF-6D). Three descriptive considerations 
formed the basis of the analysis; 1) the frequency of use across identified 
variants; 2) the degree to which instruments have been administered as partial 
measures (i.e. selective use of items or domains); and 3) a summary of data 
collection methodology. RESULTS: One hundred seventy-four articles met the 
selection criteria. In total, 9 variants were identified; the SF-36 was the most 
widely used complete measure (n=76), followed by the SF-12 (n=24), SF-6D (n=4), 
RAND-36 (n=1), and VR-36 (n=2). Partial use of instruments was common (n=54); 
some studies identified limitations regarding the Physical Functioning scale and 
tested modified measures (n=13), such as the SF-36E and the SF-36WW. Data 
collection methodology was often ambiguous or missing (n=65). CONCLUSIONS: 
The SF-36 is a common HRQoL measure within SCI research, despite oft-cited 
concerns regarding its measurement properties. Attempts to add, delete or 
modify items have resulted in a large number of variants, often with minimal 
supportive psychometric evidence. Using established generic outcome measures 
is appealing because it enables comparisons to be made across clinical 
specialties. However, the trade-off between comparability and context-specific 
validity requires further explicit consideration within the SCI research.  
 
PRM179  
RAPID IDENTIFICATION AND RECRUITMENT OF PATIENTS FROM THE HEALTH 
IMPROVEMENT NETWORK (THIN) PRIMARY CARE PATIENT DATA FOR A 
HEALTH-RELATED QUALITY OF LIFE (HRQOL) STUDY OF PATIENTS WITH 
ATRIAL FIBRILLATION (AF) IN THE UNITED KINGDOM  
Vial D1, Thompson M1, Cockbain C2, Hogan S2, Johnson M1, Bourke A1 
1Cegedim Strategic Data Medical Research Ltd, London, UK, 2Sanofi, Guildford, UK  
A46 V A L U E  I N  H E A L T H  1 6  ( 2 0 1 3 )  A 1 - A 2 9 8  
  
 
OBJECTIVES: A multi-centre, prospective, observational study aimed to recruit 
500 newly diagnosed AF patients and 500 matched controls to assess AF 
symptom burden and HRQOL using THIN UK primary care data. Patient 
enrolment as soon after diagnosis as possible was vital. Existing methodology of 
identifying patients from fully processed data would not have enrolled patients 
as quickly as necessary to assess newly diagnosed AF. The objective was to 
assess the effectiveness of a novel methodology used to recruit patients as soon 
after diagnosis as possible from THIN. METHODS: Cases and controls matched 
by age, gender and geography were identified as soon as data were received from 
THIN practices rather than after data were fully processed (normal route for 
identifying patients). Patients were therefore identified within one week of 
diagnosis being recorded. Practices were contacted by THIN staff and asked to 
confirm eligibility. Practices invited eligible patients to participate, ensuring no 
direct contact between THIN staff and patients. Patients were asked to complete 
HRQOL questionnaires at enrolment, 6 and 12 months’ follow-up. RESULTS: 
Within 18 months, this method was successful in recruiting beyond the 
necessary sample size (516 case-control pairs). This methodology minimised the 
impact of recruitment and follow-up on clinical management of patients, who 
were seen at a frequency determined in accordance with their normal medical 
care only. Diagnostic assessments of patients were not required and so, other 
than the questionnaires, there was no additional burden to normal clinical 
practice. CONCLUSIONS: This is an innovative method for patient recruitment 
using THIN primary care patient data. Newly diagnosed AF patients who might 
be eligible and for whom clinical information is already available can be quickly 
identified. Large numbers of newly diagnosed patients can be recruited more 
rapidly compared to existing methods and followed up in an efficient and cost-
effective way.  
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ADHERENCE  
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OBJECTIVES: To target patients with “personalized” interventions with the 
highest probability of success, understanding what works with other behaviors 
provides empirical guidance, as few outcomes are explicitly medication 
adherence-related. This study's purpose is to glean 1) the characteristics of 
individuals or interventions examined in “tailored” or “targeted” health 
communication interventions, and 2) the components or combination of 
successful strategies tailored to the individual's needs and targeted to the social 
groups in which the patient is embedded. METHODS: A systematic review was 
conducted, with articles identified via searches in MEDLINE and Embase, using 
keywords representing individual, interventional, and behavioral factors. 
Inclusion criteria: published peer-reviewed articles in English, 2000-2012; 77 
studies reflected behavioral outcomes (medication adherence, preventive 
screening, health promotion, and self-management of disease). The review 
specified individual factors (sociodemographic, behavioral, contextual, disease) 
as well as elements upon which interventions were customized (delivery, 
content, form, dose/frequency, setting, level of analysis). RESULTS: Across all 
outcomes assessed (n=133), 52.6% of tailored or targeted interventions 
demonstrated statistically significant benefit, with additional 12.8% effective (not 
statistically), 9.8% mixed, 24.8% non-significant. Regarding behaviors associated 
with multiple morbidities: most studies evidenced health promoting effects 
(medication adherence, 66.7%; diet/obesity, 65.9%; physical activity, 47.4%; 
screening, 71.4%). Disease-specific outcomes reflected stronger findings. 
Individual characteristics were clustered into groups for analysis, with 
significantly positive effects for 3 of 4 clusters: sociodemographic, 59.0%; 
behavioral, 63.4%, contextual, 52.6%. Within group differences indicated support 
for specific factors within each cluster (age vs. education, barriers vs. self-
efficacy). Effects were moderated by intervention-type (tailored vs 
tailored+targeted). CONCLUSIONS: A matrix developed for this review permits a 
refined approach to creating interventions focusing on the interaction (“person x 
intervention”) features of effective strategies. Several candidate characteristics of 
patients to prioritize in medication adherence program development were 
identified, using evidenced-based selection of patient-centered strategies that 
appropriately match what has worked and for whom.  
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OBJECTIVES: We describe the process and progress of the Foundation for the NIH 
Biomarkers Consortium Project Team, a public-private partnership of 
government, academia, non-profit, and industry. The goal is development and 
qualification of a new ABSSSI PRO instrument incorporating reliable, well-
defined and relevant endpoints for patients in terms of how they feel and 
function in clinical trials of antibacterial drugs for ABSSSI. METHODS: We 
adhered to the U.S. Food and Drug Administration (FDA) PRO Guidance for 
instrument development (2009) and the 2010 FDA qualification process for drug 
development tools (DDTs). This guidance describes the process for DDTs 
intended for use in multiple drug development programs, the goal of the current 
effort. Once qualified, drug developers can use DDTs for the qualified context in 
Investigational New Drug (IND) and New Drug Application (NDA)/Biological 
License Application (BLA) submissions without FDA reconsideration of the DDTs 
suitability. RESULTS: The initial phase of instrument development included a 
literature review and gap analysis (see Cimms et al., 2013 ISPOR abstracts) and 
interviews with 9 clinical experts. The most commonly reported symptoms were 
pain and tenderness across all ABSSSI subtypes- cellulitis (n=8), wound infection 
(n=7), and abscess (n=7). These efforts led to the development of a study protocol 
and interview guide to elicit concepts from ABSSSI patients. Following 
qualitative analysis of the interview transcripts, the team will draft a PRO 
instrument based on key concepts identified from ABSSSI patients and experts. 
The draft PRO will be evaluated by an expert panel and refined through cognitive 
debriefing interviews with patients. CONCLUSIONS: A consortium-based 
approach was useful and efficient in developing a new draft PRO measure for 
ABSSSI, which incorporates published literature and data from qualitative 
interviews. The team is planning a similar approach for development of a draft 
clinician reported outcome for ABSSSI and a CABP PRO.  
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OBJECTIVES: a) Determine the effect of utility transformations on the fit of linear 
regression used to map psychometric disease-specific instrument scores to 
disease-specific utility scores and b) determine whether the model fit is 
dependent upon the correlation between the disease specific and non-specific 
items of the preference-based instrument. METHODS: We compare regression 
models mapping scores from the UCLA Prostate Cancer Index (PCI), a 
psychometric instrument measuring Health Related Quality of Life for prostate 
cancer patients, to utility responses from PORPUS-U, a prostate cancer-specific 
utility instrument with disease-specific and generic subscales. Models were 
fitted using a dataset from prostate cancer patients, while fit was assessed on 
three separate datasets, using the Root Mean Squared Error (RMSE) in the 
retransformed scale. The often poor fit of regression-based mapping models may 
be due to limited overlap between the constructs addressed by preference-based 
and psychometric instruments. We investigated this hypothesis employing a 
simulation procedure where we: a) fitted a multivariate regression model 
estimating how the generic subscales depend on the disease-specific ones, b) 
used these estimates, with varying noise, to simulate generic subscale scores, c) 
calculated utility scores from the true disease-specific and simulated generic 
subscales, d) applied linear regression to map PCI scales to “semi”-simulated 
PORPUS-U utilities, and f) evaluated the mapping using RMSE, determining 
whether a “tighter” correlation structure improves the fit. RESULTS: The arcsin 
transformation appears to give the best fit, with RMSE values of 0.0405, 0.0605 
and 0.0457 for the three test datasets. The simulation experiments showed that 
larger correlation between disease specific and non-disease specific instrument 
domains only yields a marginal benefit in the mapping. CONCLUSIONS: 
Transforming utility scores does affect model fit, and appears to be an important 
step in utility mapping. Limited construct overlap between disease-specific and 
generic items in prostate cancer quality of life instruments did not evidently 
explain suboptimal fit in our mapping models.  
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OBJECTIVES: To study to what extent an opt-out option in a Discrete Choice 
Experiment (DCE) influences the attribute estimates and the conclusions drawn 
from the DCE. METHODS: A questionnaire was sent to 2,500 Dutch Diabetes 
Mellitus Type 2 (DM2) patients, each questionnaire contained 9 choice tasks with 
and 9 without an opt-out alternative. Panel-mixed-logit models were used to 
estimate the relative importance of the five attributes included (menu schedule, 
physical activity (PA) schedule, consult structure, expected outcome and out-of-
pocket costs). It was empirically tested whether the relative importance of the 
attributes differed between a DCE with or without opt-out alternative. 
Additionally, it was tested whether results differed between respondents that 
were offered the opt-out option in the first 9 choice tasks and those who could 
choose to opt-out only in the second 9 choice tasks. RESULTS: In both datasets 
(with and without opt-out), consult structure (β=-0.54, β=-0.53), expected 
outcome (β=0.64, β=0.77) and out-of-pocket costs (β=-0.79, β=-0.67) showed 
significant attribute estimates (P<.001). However, the relative importance of 
these attributes differed between both datasets. The frequency of choosing to 
opt-out was higher among participants that first had this option, compared to 
respondents that were first forced to make a choice. The regression analyses on 
these subgroups showed different results with respect to the elaborate PA 
schedule (β=0.10; P>.05 versus β=0.13; P<.05). CONCLUSIONS: Conclusions drawn 
